Factor viii inhibitor bypassing activity

Feiba 1000 U

50 u/ml injection, powder, for solutionSingaporeAuthorisedAuthorised 20 Apr 1999

In other countries

The same active substances on other registers, the same brand first.

Feiba NFCanada · 3250 UNIT / VIAL · Kit, Powder For Solution · Takeda Canada INCSame brand
Feiba NFCanada · 1300 UNIT / VIAL · Kit, Powder For Solution · Takeda Canada INCSame brand
Feiba NFCanada · 650 UNIT / VIAL · Kit, Powder For Solution · Takeda Canada INCSame brand
Feiba 100 U/ml prašak i otapalo za otopinu za infuzijuCroatia · Prašak i otapalo za otopinu za infuziju · Baxalta Innovations GmbH, Industriestrasse 67, Beč, AustrijaSame brand
Feiba 50 U/ml prašak i otapalo za otopinu za infuzijuCroatia · prašak i otapalo za otopinu za infuziju · Baxalta Innovations GmbH, Industriestrasse 67, Beč, AustrijaSame brand
FeibaItaly · Polvere e solvente per soluzione iniettabile · Baxalta Innovations GMBHSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Factor viii inhibitor bypassing activity

Feiba 1000 U

50 u/ml injection, powder, for solutionSingaporeAuthorisedAuthorised 20 Apr 1999

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

FEIBA 100 E/ml, poeder en oplosmiddel voor oplossing voor infusieNetherlands · Poeder en oplosmiddel voor oplossing voor infusie · Baxalta Innovations GmbH

FEIBA 25 U/mlRomania · 25U/ml · pulb+solv. pt. sol. perf. · Baxalta Innovations GMBH

FEIBA 50 U/mlRomania · 50U/ml · pulb+solv. pt. sol. perf. · Baxalta Innovations GMBH

Feiba NFSerbia · 500j./20mL · prašak i rastvarač za rastvor za infuziju · Takeda DOO

Feiba 50U Powder&SolventSaudi Arabia · Takeda Manufacturing Austria AG

Feiba 50U Powder&SolventSaudi Arabia · Baxter AG

Autoplex, Feiba Nf, Feiba VhUnited States · 500U · For Injection · Takeda Pharmaceuticals U.S.A., Inc.

Autoplex, Feiba Nf, Feiba VhUnited States · 1000U · For Injection · Takeda Pharmaceuticals U.S.A., Inc.

Autoplex, Feiba Nf, Feiba VhUnited States · 2500U · For Injection · Takeda Pharmaceuticals U.S.A., Inc.

octaplasLG 45-70 mg/ml otopina za infuzijuCroatia · otopina za infuziju · Octapharma (IP) SPRL, Allee De La Recherche 65, Anderlecht, Belgija

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Sciences Authority / data.gov.sg

Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence

Licence: Singapore Open Data Licence 1.0 · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Factor viii inhibitor bypassing activity
Strength: 50 u/ml
Dosage form: injection, powder, for solution
Route: intravenous
Register: Singapore (HSA)
Status: Authorised
Status in the register: Registered
Authorised: 20 Apr 1999
Registration: SIN10886P
Marketing authorisation holder: Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.
Manufacturer: Takeda Manufacturing Austria AG / Siegfried Hameln GmbH (Solvent), AUSTRIA / GERMANY
ATC code: B02BD01
Group: Blood and blood-forming organs
Supply: Prescription Only